> Detailanzeige

Fehm, Tanja N.; Welslau, Manfred; Müller, Volkmar; Lüftner, Diana; Schütz, Florian; Fasching, Peter A.; Janni, Wolfgang; Thomssen, Christoph; Witzel, Isabell; Beierlein, Milena; Belleville, Erik; Untch, Michael; Thill, Marc; Tesch, Hans; Ditsch, Nina; Lux, Michael P.; Aktas, Bahriye; Banys-Paluchowski, Maggie; Kolberg-Liedtke, Cornelia; Hartkopf, Andreas D.; Wöckel, Achim; Kolberg, Hans-Christian; Harbeck, Nadia; Stickeler, Elmar

Update Breast Cancer 2022 Part 5 – Early Stage Breast Cancer

Literatur-
verwaltung

Zur
Merkliste

Lösche von
Merkliste

Per Whatsapp teilen

Schließen

Merkliste



Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
  • Medientyp: E-Artikel
  • Titel: Update Breast Cancer 2022 Part 5 – Early Stage Breast Cancer
  • Beteiligte: Fehm, Tanja N.; Welslau, Manfred; Müller, Volkmar; Lüftner, Diana; Schütz, Florian; Fasching, Peter A.; Janni, Wolfgang; Thomssen, Christoph; Witzel, Isabell; Beierlein, Milena; Belleville, Erik; Untch, Michael; Thill, Marc; Tesch, Hans; Ditsch, Nina; Lux, Michael P.; Aktas, Bahriye; Banys-Paluchowski, Maggie; Kolberg-Liedtke, Cornelia; Hartkopf, Andreas D.; Wöckel, Achim; Kolberg, Hans-Christian; Harbeck, Nadia; Stickeler, Elmar
  • Erschienen: Georg Thieme Verlag KG, 2023
  • Erschienen in: Geburtshilfe und Frauenheilkunde, 83 (2023) 3, Seite 289-298
  • Sprache: Deutsch
  • DOI: 10.1055/a-2018-9053
  • ISSN: 0016-5751; 1438-8804
  • Schlagwörter: Maternity and Midwifery ; Obstetrics and Gynecology
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:title>Abstract</jats:title><jats:p>The treatment of patients with early stage breast cancer has changed in recent years due to the introduction of pembrolizumab, olaparib, and abemaciclib. These and other drugs with the same class of active ingredient are currently in trial for various indications. This review article summarizes the latest results that have either been presented at major conferences such as the ESMO 2022 or published recently in international journals. This includes reports on newly discovered breast cancer genes, atezolizumab in neoadjuvant therapy in HER2-positive patients, long-term data from the APHINITY study, and on how preoperative peritumoral application of local anesthetics can influence the prognosis. We also present solid data on dynamic Ki-67 from the ADAPT studies.</jats:p>
  • Zugangsstatus: Freier Zugang